Welcome to our dedicated page for Healthy Extracts news (Ticker: HYEX), a resource for investors and traders seeking the latest updates and insights on Healthy Extracts stock.
Healthy Extracts Inc. reports developments in science-based nutraceutical supplements, oral delivery technology, and precision-dose gummy manufacturing. The company develops, manufactures, and markets proprietary supplements for brain, heart, and gut health, with product formats that include gel packs, functional drinking straws, and gummies through its Gummy USA subsidiary.
Recurring company news includes revenue updates, direct-to-consumer and retail sales activity, Amazon subscription trends, product launches such as STAT10 and 4Sleep, and B2B manufacturing relationships for private-label and branded gummy products. Coverage also reflects the completed Gummy USA combination, which added a HACCP, GMP-certified and FDA-registered manufacturing facility to the company’s nutraceutical platform.
Healthy Extracts Inc. (OTCQB: HYEX) has launched two high-potency products: Organic Citrus Bergamot for Women and Organic Citrus Bergamot, available exclusively on Amazon. These products feature Citrus Bergamot SuperFruit™, the strongest bergamot extract, shown in over 17 clinical studies to support heart health and maintain healthy cholesterol and blood sugar levels. The company anticipates a market growth opportunity, expecting sales to double in the next year as awareness of these heart health supplements increases.
Healthy Extracts Inc. (OTCQB: HYEX) has initiated a double-blind placebo-controlled clinical trial to evaluate the effectiveness of UBN RELIEF™ in preventing and alleviating migraine symptoms while enhancing cognitive function. Administered by Dr. Neil Wolkodoff, the trial is expected to conclude in November 2021. Previous studies indicated that UBN RELIEF™ led to a 61% reduction in headache duration and significantly improved various symptoms. Healthy Extracts aims to leverage these findings to expand its market reach in the growing brain health supplement sector, projected to reach $13.4 billion by 2028.
On September 14, 2021, Healthy Extracts Inc. (OTCQB: HYEX) announced the publication of a pilot study in the Annals of Reviews and Research. The study highlights the effectiveness of its Ultimate Brain Nutrients™ (UBN™) ACTIVATE™ product, which can enhance brain activity by up to 46%. According to Healthy Extracts' president, Duke Pitts, this clinical validation supports their growing portfolio and market competitiveness, particularly in the expanding brain health supplement market projected to reach $13.4 billion by 2028.
Healthy Extracts Inc. (OTCQB: HYEX) has launched Ultimate Brain Nutrients RELIEF™, a patent-pending natural formulation designed to alleviate migraine symptoms. Clinical research indicates that daily use of UBN RELIEF results in 61% shorter symptom duration, 60% fewer missed workdays, and notable reductions in light and sound sensitivity. With migraines affecting an estimated 1 billion people globally, UBN RELIEF offers a cost-effective, natural alternative to traditional drug treatments, which can exceed $9,500 annually. The product is part of a growing market expected to reach $13.4 billion by 2028.
Healthy Extracts Inc. (OTCQB: HYEX) has entered into an exclusive licensing and manufacturing agreement with Gelteq Pty Ltd to develop a new oral delivery system for its plant-based health formulations in the U.S. and Canada. This collaboration allows Healthy Extracts to use Gelteq's patented gelification technology, enabling the creation of easy-to-consume gel packs for their Citrus Bergamot and Ultimate Brain Nutrients™ products. The gel format enhances bioavailability, reduces choking risks, and aims to improve customer convenience, with plans to launch the first product by Q3 2021.
Healthy Extracts Inc. (OTCQB: HYEX) has launched a brand awareness campaign in partnership with InvestingChannel, aiming to promote its clinically proven plant-based products for heart and brain health. The campaign targets a unique audience of over 18 million retail investors and aims to raise awareness of Healthy Extracts' formulations as well as potential growth in the natural health supplement market, projected to reach $24.8 billion by 2027. Key components include newsletters and native advertisements across various platforms, emphasizing the company's successful acquisitions and upcoming product launches.
Healthy Extracts Inc. (OTCQB: HYEX) launched a new weekly show on Clubhouse, focusing on enhancing mental health and energy through natural brain function optimization. Premiering every Thursday at 7:30 p.m. Eastern, the show features Dr. James Rouse and Danielle Haden. Their inaugural topic, 'The Secret Science of the Integrated Entrepreneur,' aims to educate listeners on achieving balance in work and health. The company also introduced its new product, UBN ACTIVATE, clinically shown to boost brain activity by 46% for eight hours, catering especially to entrepreneurs and creatives.
Healthy Extracts Inc. (OTCQB: HYEX) has launched Ultimate Brain Nutrients (UBN) ACTIVATE, a scientifically backed product aimed at enhancing cognitive function. ACTIVATE can increase brain activity by 46%, improving attention, memory, and mood. The proprietary Fuel4Thought® formulation is naturally derived, caffeine-free, and sugar-free, with effects lasting over eight hours. The brain health supplements market is projected to reach $13.4 billion by 2028, driven by rising consumer demand for nootropics. The company is committed to developing natural, clinically proven nutraceuticals.
Healthy Extracts Inc. (OTCQB: HYEX) has announced the addition of Dr. Joel Kahn, a triple board-certified cardiologist, to its Medical Board. Dr. Kahn has leveraged BergametNA Citrus Bergamot SuperFruit™ in his practice, demonstrating positive results in arterial age reversal and cardiovascular health. This strategic move aims to enhance the company's credibility and expand its market reach. Healthy Extracts focuses on developing plant-based products for heart and brain health, backed by clinical studies.
Healthy Extracts Inc. (OTCQB: HYEX) reported a significant 71% revenue increase for the year ended December 31, 2020, totaling $1.28 million, up from $748,377 in 2019. This growth was fueled by a shift to health nutrition products and the elimination of convertible debt, raising shareholder equity by $3.7 million. Key accomplishments in 2020 included the launch of innovative health products and the completion of pivotal clinical studies. The company rebranded and upgraded to OTCQB, signaling a positive outlook for future expansion and growth.